MedPath

Behavioral Economics for Activity Motivation in Adolescents (BEAM)

Not Applicable
Completed
Conditions
Insulin Resistance
PreDiabetes
Polycystic Ovary Syndrome
Type 2 Diabetes
Interventions
Behavioral: 2RLW
Behavioral: 2RGW
Behavioral: 1FLD
Behavioral: 2FLW
Behavioral: 1RLD
Behavioral: 1FLW
Behavioral: 2FLD
Behavioral: 2FGW
Behavioral: 1RGD
Behavioral: 1RGW
Behavioral: 2RLD
Behavioral: 2RGD
Behavioral: 1RLW
Behavioral: 1FGD
Behavioral: 2FGD
Behavioral: 1FGW
Registration Number
NCT04874415
Lead Sponsor
University of Pittsburgh
Brief Summary

There is an urgent need to engineer targeted physical activity interventions that are effective and scalable for obese adolescents and young adults (AYA) with type 2 diabetes (T2D), who often have very low levels of physical activity. The BEAM Trial is a proposed mobile health (mHealth) intervention that uses behavioral economic-informed financial incentives and text messaging to promote physical activity in AYA with T2D and prediabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
    1. Males or females age 13 to 22 years.
    1. Overweight or obese (BMI ≥85th percentile for age/sex, or ≥25 kg/m2 for participants ≥18 years)
    1. Diagnosis with prediabetes or type 2 diabetes
    1. Consent (subjects 18 and older), Parental/guardian permission (subjects 13-17), assent (subjects 13-17)
    1. Willingness to wear Fitbit during waking hours daily for duration of run-in and intervention.
    1. Possession of a smartphone.
Exclusion Criteria
    1. Potential subject unable to speak or read in English
    1. Severe cognitive impairment
    1. Permanent or temporary physical disability that impairs ambulation or precludes engagement in MVPA
    1. Current pregnancy
    1. Previously-diagnosed or current restrictive or purging eating disorder
    1. Moderate to vigorous physical activity (MVPA) >30 minutes per day or Fitbit wear < 4 days during second week of 2-week run-in period

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Condition 62RLW2RLW=Two texts per day, ramped goal, loss incentive, weekly goal time period.
Condition 82RGW2RGW=Two texts per day, ramped goal, gain incentive, weekly goal time period.
Condition 91FLD1FLD=One text per day, fixed goal, loss incentive, daily goal time period.
Condition 142FLW2FLW=Two texts per day, fixed goal, loss incentive, weekly goal time period.
Condition 11RLD1RLD=One text per day, ramped goal, loss incentive, daily goal time period.
Condition 101FLW1FLW=One text per day, fixed goal, loss incentive, weekly goal time period.
Condition 132FLD2FLD=Two texts per day, fixed goal, loss incentive, daily goal time period.
Condition 162FGW2FGW=Two texts per day, fixed goal, gain incentive, weekly goal time period.
Condition 31RGD1RGD=One text per day, ramped goal, gain incentive, daily goal time period.
Condition 41RGW1RGW=One text per day, ramped goal, gain incentive, weekly goal time period.
Condition 52RLD2RLD=Two texts per day, ramped goal, loss incentive, daily goal time period.
Condition 72RGD2RGD=Two texts per day, ramped goal, gain incentive, daily goal time period.
Condition 21RLW1RLW=One text per day, ramped goal, loss incentive, weekly goal time period.
Condition 111FGD1FGD=One text per day, fixed goal, gain incentive, daily goal time period.
Condition 152FGD2FGD=Two texts per day, fixed goal, gain incentive, daily goal time period.
Condition 121FGW1FGW=One text per day, fixed goal, gain incentive, weekly goal time period.
Primary Outcome Measures
NameTimeMethod
Moderate to Vigorous Physical Activity (MVPA)12 weeks

Effects of time spent in MVPA will be measured by assessing the weekly mean minutes in MVPA per day

Secondary Outcome Measures
NameTimeMethod
Daily Step Count12 weeks

Daily step count will be measured by assessing the daily mean steps

Trial Locations

Locations (1)

UPMC Children's Hospital of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath